Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns

NCT04045626 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT04045626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2019
Completion date
March 31, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive keratoconus